ValiRx plc EAJF.F Stock
ValiRx plc Price Chart
ValiRx plc EAJF.F Financial and Trading Overview
| ValiRx plc stock price | 0.02 EUR |
| Previous Close | 0.1 EUR |
| Open | 0.09 EUR |
| Bid | 0.09 EUR x N/A |
| Ask | 0.11 EUR x N/A |
| Day's Range | 0.09 - 0.09 EUR |
| 52 Week Range | 0.09 - 0.25 EUR |
| Volume | 2.27K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 9.36M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EAJF.F Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
ValiRx plc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -57.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.25 EUR |
| 52 Week Low | 0.09 EUR |
| 50-Day Moving Average | 0.11 EUR |
| 200-Day Moving Average | 0.14 EUR |
EAJF.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 102.32M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 15.30% |
| % Held by Institutions | 0.068% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:125 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.044 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of ValiRx plc
| Country | Germany |
| State | N/A |
| City | Nuneaton |
| Address | Eliot Park Innovation Centre |
| ZIP | CV10 7RH |
| Phone | 44 24 7679 6496 |
| Website | https://www.valirx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of endometriosis; and BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc was incorporated in 2000 and is based in Nuneaton, the United Kingdom.
Q&A For ValiRx plc Stock
What is a current EAJF.F stock price?
ValiRx plc EAJF.F stock price today per share is 0.02 EUR.
How to purchase ValiRx plc stock?
You can buy EAJF.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ValiRx plc?
The stock symbol or ticker of ValiRx plc is EAJF.F.
Which industry does the ValiRx plc company belong to?
The ValiRx plc industry is Biotechnology.
How many shares does ValiRx plc have in circulation?
The max supply of ValiRx plc shares is 167.44M.
What is ValiRx plc Price to Earnings Ratio (PE Ratio)?
ValiRx plc PE Ratio is now.
What was ValiRx plc earnings per share over the trailing 12 months (TTM)?
ValiRx plc EPS is -0.02 EUR over the trailing 12 months.
Which sector does the ValiRx plc company belong to?
The ValiRx plc sector is Healthcare.